Giant Mammary HamartomaSymptoms, Doctors, Treatments, Advances & More
Learn About Giant Mammary Hamartoma
Advocate Christ Outpatient Pavilion Breast Surgery
Joslyn Albright is a Surgical Oncologist practicing medicine in Oak Lawn, Illinois. Dr. Albright is rated as an Advanced provider by MediFind in the treatment of Giant Mammary Hamartoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Giant Mammary Hamartoma, Intraductal Papilloma, and Lymphadenectomy. Dr. Albright is board certified in American Board Of Surgery.
Lutheran General Caldwell Breast Center
Anna Katz is a General Surgeon and a Surgical Oncologist practicing medicine in Park Ridge, Illinois. Dr. Katz is rated as an Advanced provider by MediFind in the treatment of Giant Mammary Hamartoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy. Dr. Katz is board certified in American Board Of Surgery.
OSF Little Company Of Mary - Surgery
Jilma Patrick is a General Surgeon practicing medicine in Evergreen Park, Illinois. She has been practicing medicine for over 17 years. Dr. Patrick is rated as an Advanced provider by MediFind in the treatment of Giant Mammary Hamartoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Patrick is board certified in American Board Of Surgery.
Summary: This is a phase 1b, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics of Sapu003 in combination with Exemestane in in patients with advanced mTOR-sensitive solid tumors (HR+/HER2-negative breast cancer, renal cell carcinoma \[RCC\], neuroendocrine tumors \[NETs\], tuberous sclerosis complex \[TSC\]-associated tumors, and hepatocellular carcinoma \[HCC\]).
Summary: The objective of this protocol is to develop an institution-wide liquid biopsy protocol that will establish a common process for collecting blood and corresponding archived tumor specimens for future research studies at the University Health Network's Princess Margaret Cancer Centre. Circulating cell-free nucleic acids (cfNA), including cell-free DNA (cfDNA) and cell-free RNA (cfRNA), are non-inva...